Target intelligence / Profile preview

Melanoma tumor spheroids

Molecular classification
Other
01

Overview

Melanoma tumor spheroids are three-dimensional (3D) in vitro biological models that mimic the structural and physiological complexity of solid melanoma tumors in vivo [1][2]. Unlike traditional monolayer (2D) cultures, these spheroids recreate the spatial organization of cancer cells, facilitating realistic cell-cell and cell-extracellular matrix (ECM) interactions [3]. They are characterized by the development of pathophysiological gradients, including a proliferative outer layer, a quiescent middle layer, and a hypoxic or necrotic core, which closely resemble the microenvironment of human tumors [4][5]. While they are frequently used in pharmaceutical research to evaluate the penetration and efficacy of targeted therapies (such as BRAF and MEK inhibitors) and immunotherapies, a spheroid is a complex multicellular system rather than a discrete molecular target like a receptor or enzyme [6]. Consequently, they serve as a critical bridge between simplified cell cultures and complex animal models in the drug discovery pipeline [7].

Other names
3D melanoma cultureMulticellular melanoma spheroidsMelanoma MCTSMelanoma microtissuesMelanoma multicellular tumor spheroids
02

Mechanism of action

Not applicable; melanoma tumor spheroids are multicellular in vitro models used to study drug efficacy and tumor biology rather than being a single molecular target with a specific mechanism of action.

03

Biological functions

Cell-cell interactionCell-extracellular matrix interactionHypoxia signalingMetabolic gradient formationMulticellular drug resistance
04

Disease associations

MelanomaCancer
05

Safety considerations

Lack of vascularization in modelAbsence of systemic immune componentsInconsistent oxygen and nutrient diffusion gradientsDifficulty in high-throughput standardization
06

Interacting drugs

Vemurafenib

4 more in the full profile.

07

Biomarkers

BRAF V600E mutationS100 calcium-binding proteinHMB-45 (Melanosome antigen)HIF-1 alpha (Hypoxia marker)Ki-67 (Proliferation marker)

Beyond the preview

Go deeper on Melanoma tumor spheroids.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Melanoma tumor spheroids.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call